X0202 SCHEDULE 13G/A 0001646799 XXXXXXXX LIVE 1 Common stock, par value $0.0001 per share 03/31/2026 0001853816 Dermata Therapeutics, Inc. 249845504 3525 Del Mar Heights Rd. #322 San Diego CA 92130 Rule 13d-1(c) Mitchell P. Kopin X1 0.00 211246.00 0.00 211246.00 211246.00 N 4.99 HC IN Daniel B. Asher X1 0.00 211246.00 0.00 211246.00 211246.00 N 4.99 HC IN Intracoastal Capital LLC DE 0.00 211246.00 0.00 211246.00 211246.00 N 4.99 OO Dermata Therapeutics, Inc. 3525 Del Mar Heights Rd., #322, San Diego, CA 92130 This Schedule 13G is being filed on behalf of (i) Mitchell P. Kopin, an individual ("Mr. Kopin"), (ii) Daniel B. Asher, an individual ("Mr. Asher") and (iii) Intracoastal Capital LLC, a Delaware limited liability company ("Intracoastal" and together with Mr. Kopin and Mr. Asher, collectively the "Reporting Persons"). The principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483. The principal business office of Mr. Asher is 1011 Lake Street, Suite 311, Oak Park, Illinois 60301. Mr. Kopin is a citizen of the United States of America. Mr. Asher is a citizen of the United States of America. Intracoastal is a Delaware limited liability company. Y As of the close of business on March 31, 2026, each of the Reporting Persons may have been deemed to have beneficial ownership of 211,246 shares of Common Stock, which consisted of (i) 2,334 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal ("Intracoastal Warrant 1"), (ii) 26,247 shares of Common Stock issuable upon exercise of a second warrant held by Intracoastal ("Intracoastal Warrant 2"), (iii) 147,059 shares of Common Stock issuable upon exercise of a third warrant held by Intracoastal ("Intracoastal Warrant 3") and (iv) 35,606 shares of Common Stock issuable upon exercise of a fourth warrant held by Intracoastal ("Intracoastal Warrant 4"), and all such shares of Common Stock represent beneficial ownership of approximately 4.99% of the Common Stock, based on (1) 4,022,143 shares of Common Stock outstanding as of March 25, 2026, as reported to the Reporting Persons by the Issuer, plus (2) 2,334 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1, (3) 26,247 shares of Common Stock issuable upon exercise of Intracoastal Warrant 2, (4) 147,059 shares of Common Stock issuable upon exercise of Intracoastal Warrant 3 and (5) 35,606 shares of Common Stock issuable upon exercise of Intracoastal Warrant 4. The foregoing excludes 111,453 shares of Common Stock issuable upon exercise of Intracoastal Warrant 4 because Intracoastal Warrant 4 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 4 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock. Without such blocker provision, each of the Reporting Persons may have been deemed to have beneficial ownership of 322,699 shares of Common Stock. 4.99% 0 211,246 0 211,246 N Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Mitchell P. Kopin /s/ Mitchell P. Kopin 05/13/2026 Daniel B. Asher /s/ Daniel B. Asher 05/13/2026 Intracoastal Capital LLC /s/ Mitchell P. Kopin 05/13/2026